Jose Antonio Robles-Zurita (Jose Robles-Zurita)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Acute Myocardial Infarction

Antiplatelet Therapy

Cross Sectional

Top Venues

The European journal of health economics : HEPAC : health economics in prevention and care

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jose Antonio Robles-Zurita
Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Jose Antonio Robles-Zurita, Andrew Briggs, Dikshyanta Rana, Zahidul Quayyum, Keith G Oldroyd, Uwe Zeymer, Steffen Desch, Suzanne de Waha-Thiele, Holger Thiele
Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. The European journal of health economics : HEPAC : health economics in prevention and care 21 (8) (2020)
Timothy J Iveson, Kathleen Anne Boyd, Rachel S Kerr, Jose Antonio Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David J Propper, John A Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S Wasan, James Paul
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health technology assessment (Winchester, England) 23 (64) (2020)